JP2023529371A5 - - Google Patents

Info

Publication number
JP2023529371A5
JP2023529371A5 JP2022574541A JP2022574541A JP2023529371A5 JP 2023529371 A5 JP2023529371 A5 JP 2023529371A5 JP 2022574541 A JP2022574541 A JP 2022574541A JP 2022574541 A JP2022574541 A JP 2022574541A JP 2023529371 A5 JP2023529371 A5 JP 2023529371A5
Authority
JP
Japan
Prior art keywords
dnaj
fusion protein
synuclein
group
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022574541A
Other languages
English (en)
Japanese (ja)
Other versions
JP7887366B2 (ja
JP2023529371A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/035958 external-priority patent/WO2021248038A1/en
Publication of JP2023529371A publication Critical patent/JP2023529371A/ja
Publication of JP2023529371A5 publication Critical patent/JP2023529371A5/ja
Priority to JP2026066932A priority Critical patent/JP2026120714A/ja
Application granted granted Critical
Publication of JP7887366B2 publication Critical patent/JP7887366B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022574541A 2020-06-05 2021-06-04 シヌクレイノパチーの処置のための組成物および方法 Active JP7887366B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026066932A JP2026120714A (ja) 2020-06-05 2026-04-15 シヌクレイノパチーの処置のための組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063035297P 2020-06-05 2020-06-05
US63/035,297 2020-06-05
PCT/US2021/035958 WO2021248038A1 (en) 2020-06-05 2021-06-04 Compositions and methods for the treatment of synucleinopathies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026066932A Division JP2026120714A (ja) 2020-06-05 2026-04-15 シヌクレイノパチーの処置のための組成物および方法

Publications (3)

Publication Number Publication Date
JP2023529371A JP2023529371A (ja) 2023-07-10
JP2023529371A5 true JP2023529371A5 (cg-RX-API-DMAC7.html) 2024-06-10
JP7887366B2 JP7887366B2 (ja) 2026-07-09

Family

ID=76708439

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022574541A Active JP7887366B2 (ja) 2020-06-05 2021-06-04 シヌクレイノパチーの処置のための組成物および方法
JP2026066932A Pending JP2026120714A (ja) 2020-06-05 2026-04-15 シヌクレイノパチーの処置のための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026066932A Pending JP2026120714A (ja) 2020-06-05 2026-04-15 シヌクレイノパチーの処置のための組成物および方法

Country Status (6)

Country Link
US (1) US20230234997A1 (cg-RX-API-DMAC7.html)
EP (1) EP4161953A1 (cg-RX-API-DMAC7.html)
JP (2) JP7887366B2 (cg-RX-API-DMAC7.html)
CN (1) CN116096737B (cg-RX-API-DMAC7.html)
CA (1) CA3183251A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021248038A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024026284A2 (en) * 2022-07-25 2024-02-01 Interius Biotherapeutics, Inc. Mutated polypeptides, compositions comprising the same, and uses thereof
WO2024229777A1 (zh) * 2023-05-11 2024-11-14 深圳先进技术研究院 一种aav载体及其应用
CN116590342B (zh) * 2023-05-11 2026-04-03 普递瑞(上海)医药有限公司 一种aav载体及其应用
CN117402251B (zh) * 2023-12-15 2024-02-23 中国医学科学院基础医学研究所 一种抗小g蛋白rbj的抗体及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8918616D0 (en) 1989-08-15 1989-09-27 Univ Glasgow Herpes simplex virus type 1 mutant
US5804413A (en) 1992-07-31 1998-09-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Herpes simplex virus strains for gene transfer
GB9415319D0 (en) 1994-07-29 1994-09-21 Medical Res Council HSV viral vector
US5846782A (en) 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US6093570A (en) 1995-06-07 2000-07-25 The University Of North Carolina At Chapel Hill Helper virus-free AAV production
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
EP1002119A1 (en) 1997-07-31 2000-05-24 University Of Pittsburgh Of The Commonwealth System Of Higher Education Targeted hsv vectors
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
DE69939169D1 (de) 1998-05-28 2008-09-04 Us Gov Health & Human Serv Aav5 vektoren und deren verwendung
CN1246532A (zh) * 1998-08-31 2000-03-08 复旦大学 人热休克关联蛋白编码序列、其编码的多肽及制备方法
US7465583B2 (en) 2000-06-01 2008-12-16 The University Of North Carolina At Chapel Hill Duplexed parvovirus vectors
CN1440420A (zh) * 2000-07-07 2003-09-03 万能药制药公司 预防神经组织损伤和治疗α-共核蛋白疾病的方法
WO2002053703A2 (en) 2001-01-05 2002-07-11 Children's Hospital, Inc. Aav2 vectors and methods
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
EP1828390B1 (en) 2004-12-15 2012-06-13 The University Of North Carolina At Chapel Hill Chimeric vectors
WO2008002465A2 (en) * 2006-06-23 2008-01-03 The Feinstein Institute For Medical Research INHIBITORS OF Aβ AND SYNUCLEIN AGGREGATION
EP2396343B1 (en) 2009-02-11 2017-05-17 The University of North Carolina At Chapel Hill Modified virus vectors and methods of making and using the same
US9169494B2 (en) 2010-01-12 2015-10-27 The University Of North Carolina At Chapel Hill Restrictive inverted terminal repeats for viral vectors
WO2011097456A2 (en) 2010-02-05 2011-08-11 The University Of North Carolina At Chapel Hill Compositions and methods for enhanced parvovirus transduction
WO2014053879A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
EP2929045B1 (en) * 2012-12-05 2020-12-02 SOLA Biosciences LLC Protein expression enhancing polypeptides
WO2018058088A1 (en) * 2016-09-26 2018-03-29 SOLA Biosciences, LLC Cell-associated secretion-enhancing fusion proteins
WO2019161386A1 (en) 2018-02-19 2019-08-22 New York University Alpha-synuclein single domain antibodies
WO2021138582A1 (en) * 2019-12-31 2021-07-08 The Johns Hopkins University Fusion proteins and methods of use thereof

Similar Documents

Publication Publication Date Title
ES2230569T3 (es) Funciones accesorias para uso en la produccion de viriones aav recombinantes.
JP2020522269A5 (cg-RX-API-DMAC7.html)
AU2018303230B2 (en) Improved AAV capsid production in insect cells
CA2985945C (en) Capsid
ES2703814T3 (es) Terapia génica para la enfermedad de Fabry
Lu Recombinant adeno-associated virus as delivery vector for gene therapy—a review
CA2418442C (en) Novel helper functions for recombinant vector production
ES2302331T3 (es) Vectores que codifican genomas de aav recombinantes.
US10413598B2 (en) Factor IX gene therapy
JP2023524414A5 (cg-RX-API-DMAC7.html)
US20170067028A1 (en) Radiolabeling of adeno associated virus
JP2022508182A5 (cg-RX-API-DMAC7.html)
JP2021512649A5 (cg-RX-API-DMAC7.html)
TW202005978A (zh) 新穎肝靶向腺相關病毒載體
KR20160131032A (ko) 곤충 세포에서 생산된 더욱 향상된 aav 벡터
TW201546285A (zh) 腺相關病毒因子viii載體
JP2025069281A (ja) 調節可能な発現系
JP7616668B2 (ja) Ube3a遺伝子および発現カセットならびにそれらの使用
JP2024159800A (ja) 筋肉発現のためのハイブリッドプロモーター
JP2017529395A5 (cg-RX-API-DMAC7.html)
JP2023524024A5 (cg-RX-API-DMAC7.html)
JP2023520927A5 (cg-RX-API-DMAC7.html)
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2025513887A (ja) 肝臓における遺伝子発現を脱標的化するための要素
US20240425879A1 (en) Compositions and methods for adeno-associated (aav) virus dnase expression